Clinical Trials Browser

Phase 3 × Pancreatic Neoplasms × Omeprazole × Clear all

NCT05680870 2025-09-09

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms